Aflac (AFL) Competitors $111.32 +1.64 (+1.50%) (As of 11/15/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends AFL vs. MET, PRU, HUM, CNC, UNM, PRI, LNC, CNO, OSCR, and CIAShould you be buying Aflac stock or one of its competitors? The main competitors of Aflac include MetLife (MET), Prudential Financial (PRU), Humana (HUM), Centene (CNC), Unum Group (UNM), Primerica (PRI), Lincoln National (LNC), CNO Financial Group (CNO), Oscar Health (OSCR), and Citizens (CIA). Aflac vs. MetLife Prudential Financial Humana Centene Unum Group Primerica Lincoln National CNO Financial Group Oscar Health Citizens MetLife (NYSE:MET) and Aflac (NYSE:AFL) are both large-cap finance companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, institutional ownership, risk, community ranking, valuation, media sentiment, analyst recommendations, dividends and earnings. Do insiders & institutionals believe in MET or AFL? 89.8% of MetLife shares are owned by institutional investors. Comparatively, 67.4% of Aflac shares are owned by institutional investors. 0.3% of MetLife shares are owned by company insiders. Comparatively, 0.9% of Aflac shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Is MET or AFL more profitable? Aflac has a net margin of 22.02% compared to MetLife's net margin of 5.27%. MetLife's return on equity of 20.01% beat Aflac's return on equity.Company Net Margins Return on Equity Return on Assets MetLife5.27% 20.01% 0.86% Aflac 22.02%16.34%3.15% Which has higher earnings & valuation, MET or AFL? Aflac has lower revenue, but higher earnings than MetLife. Aflac is trading at a lower price-to-earnings ratio than MetLife, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMetLife$66.91B0.86$1.58B$4.9616.80Aflac$18.70B3.31$4.66B$6.6416.77 Is MET or AFL a better dividend stock? MetLife pays an annual dividend of $2.18 per share and has a dividend yield of 2.6%. Aflac pays an annual dividend of $2.00 per share and has a dividend yield of 1.8%. MetLife pays out 44.0% of its earnings in the form of a dividend. Aflac pays out 30.1% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. MetLife has raised its dividend for 11 consecutive years and Aflac has raised its dividend for 43 consecutive years. Which has more risk & volatility, MET or AFL? MetLife has a beta of 1.05, meaning that its stock price is 5% more volatile than the S&P 500. Comparatively, Aflac has a beta of 0.96, meaning that its stock price is 4% less volatile than the S&P 500. Does the media prefer MET or AFL? In the previous week, MetLife had 9 more articles in the media than Aflac. MarketBeat recorded 28 mentions for MetLife and 19 mentions for Aflac. Aflac's average media sentiment score of 1.07 beat MetLife's score of 0.70 indicating that Aflac is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment MetLife 15 Very Positive mention(s) 1 Positive mention(s) 10 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Aflac 12 Very Positive mention(s) 1 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Does the MarketBeat Community prefer MET or AFL? MetLife received 369 more outperform votes than Aflac when rated by MarketBeat users. Likewise, 73.79% of users gave MetLife an outperform vote while only 56.74% of users gave Aflac an outperform vote. CompanyUnderperformOutperformMetLifeOutperform Votes94673.79% Underperform Votes33626.21% AflacOutperform Votes57756.74% Underperform Votes44043.26% Do analysts recommend MET or AFL? MetLife presently has a consensus price target of $88.46, indicating a potential upside of 6.16%. Aflac has a consensus price target of $97.93, indicating a potential downside of 12.03%. Given MetLife's stronger consensus rating and higher probable upside, equities research analysts plainly believe MetLife is more favorable than Aflac.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score MetLife 0 Sell rating(s) 0 Hold rating(s) 13 Buy rating(s) 0 Strong Buy rating(s) 3.00Aflac 3 Sell rating(s) 9 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.00 SummaryMetLife beats Aflac on 12 of the 21 factors compared between the two stocks. Ad Behind the MarketsUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time Nvidia makes a chip?Click Here to learn how to get in now >>> Get Aflac News Delivered to You Automatically Sign up to receive the latest news and ratings for AFL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AFL vs. The Competition Export to ExcelMetricAflacAccident & health insurance IndustryFinance SectorNYSE ExchangeMarket Cap$61.84B$24.76B$11.00B$19.82BDividend Yield1.81%2.28%5.94%3.50%P/E Ratio16.7710.1028.4842.29Price / Sales3.311.6845.0420.83Price / Cash14.1911.5118.4921.65Price / Book2.491.743.694.66Net Income$4.66B$1.71B$998.34M$983.45M7 Day Performance2.82%1.98%-0.06%-2.12%1 Month Performance-3.21%2.45%1.86%-0.39%1 Year Performance36.14%35.98%24.78%23.34% Aflac Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AFLAflac4.5752 of 5 stars$111.32+1.5%$97.93-12.0%+37.2%$61.84B$18.70B16.7712,785Short Interest ↓Positive NewsMETMetLife4.9741 of 5 stars$82.60+0.7%N/A+34.3%$57.19B$66.91B16.6545,000Analyst UpgradeShort Interest ↓News CoveragePRUPrudential Financial4.968 of 5 stars$125.75+0.4%N/A+34.6%$44.77B$50.89B11.1840,658Analyst UpgradeNews CoverageHUMHumana4.7013 of 5 stars$282.97-2.2%N/A-46.3%$34.07B$115.01B25.0667,600Short Interest ↑Analyst RevisionCNCCentene4.9686 of 5 stars$58.69+1.1%N/A-21.5%$29.63B$154.00B10.1967,700Insider BuyingShort Interest ↑Analyst RevisionUNMUnum Group4.8582 of 5 stars$72.26+1.7%N/A+73.9%$13.20B$12.39B7.8210,812Analyst UpgradeInsider SellingAnalyst RevisionNews CoveragePRIPrimerica4.6829 of 5 stars$296.82-1.1%N/A+46.3%$9.90B$2.82B22.683,450Analyst DowngradeInsider SellingBuyback AnnouncementShort Interest ↓News CoverageLNCLincoln National4.9093 of 5 stars$34.92-0.3%N/A+51.7%$5.95B$13.63B24.9411,024Dividend AnnouncementCNOCNO Financial Group4.2249 of 5 stars$39.05-0.5%N/A+55.3%$4.03B$4.15B15.753,500Dividend AnnouncementInsider SellingShort Interest ↑News CoverageOSCROscar Health3.5003 of 5 stars$15.45+14.6%N/A+108.0%$3.74B$5.86B-257.462,400Insider BuyingNews CoverageGap UpHigh Trading VolumeCIACitizens1.0484 of 5 stars$4.52+3.0%N/A+38.9%$225.41M$240.68M10.51220 Related Companies and Tools Related Companies MET Competitors PRU Competitors HUM Competitors CNC Competitors UNM Competitors PRI Competitors LNC Competitors CNO Competitors OSCR Competitors CIA Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:AFL) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aflac Incorporated Please log in to your account or sign up in order to add this asset to your watchlist. Share Aflac With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.